FDA.reportPublic FDA data

TRIETHYL CITRATE

Substance profile for UNII 8Z96QXD6UM, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Chemical structure for TRIETHYL CITRATE
Structure render from PubChem CID 6506

Substance Identity#

UNII
8Z96QXD6UM
Preferred term
TRIETHYL CITRATE
Registry number
77-93-0
EC number
201-070-7
Ingredient type
INGREDIENT SUBSTANCE
Molecular formula
C12H20O7
Chemical structure for TRIETHYL CITRATE
Structure render from PubChem CID 6506

Chemical And Database Identifiers#

InChIKey
DOOTYTYQINUNNV-UHFFFAOYSA-N
SMILES
CCOC(=O)CC(O)(CC(=O)OCC)C(=O)OCC
RxCUI
1310554
PubChem
6506
NCIt
C76736
INN ID
0

Open Chemistry Sources#

Source, Identifier, Link table
SourceIdentifierLink
PubChem Compound6506https://pubchem.ncbi.nlm.nih.gov/compound/6506
PubChem InChIKey SearchDOOTYTYQINUNNV-UHFFFAOYSA-Nhttps://pubchem.ncbi.nlm.nih.gov/#query=DOOTYTYQINUNNV-UHFFFAOYSA-N
RxNorm1310554https://mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=1310554
NCI ThesaurusC76736https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C76736
FDA Substance Registration System8Z96QXD6UMhttps://precision.fda.gov/uniisearch/srs/unii/8Z96QXD6UM
European Community number201-070-7https://commonchemistry.cas.org/results?q=201-070-7

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
TRIETHYL CITRATEINACTIVE INGREDIENT8Z96QXD6UMPANTOPRAZOLE SODIUM2
Triethyl CitrateINACTIVE INGREDIENT8Z96QXD6UMPANTOPRAZOLE SODIUM5
TRIETHYL CITRATEINACTIVE INGREDIENT8Z96QXD6UMThese highlights do not include all the information needed to use Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate Extended-Release Capsules (MAS-ER) safely and effectively. See full prescribing information for MAS-ER Capsules. Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate Extended-Release Capsules (mixed salts of a single-entity amphetamine product), CII Initial U.S. Approv17
TRIETHYL CITRATEINACTIVE INGREDIENT8Z96QXD6UMThese highlights do not include all the information needed to use omeprazole delayed-release capsules safely and effectively. See full prescribing information for omeprazole delayed-release capsules. OMEPRAZOLE Delayed-Release Capsules USP Initial U.S. Approval: 19895
TRIETHYL CITRATEINACTIVE INGREDIENT8Z96QXD6UMMEDPURINE3
TRIETHYL CITRATEINACTIVE INGREDIENT8Z96QXD6UMThese highlights do not include all the information needed to use PANTOPRAZOLE sodium delayed-release tablets, USP safely and effectively. See full prescribing information for PANTOPRAZOLE sodium delayed-release tablets, USP. PANTOPRAZOLE sodium delayed-release tablets, USP, for oral administration Initial U.S. approval: 200011
TRIETHYL CITRATEINACTIVE INGREDIENT8Z96QXD6UMThese highlights do not include all the information needed to use OMEPRAZOLE delayed-release capsules, USP safely and effectively. See full prescribing information for OMEPRAZOLE delayed-release capsules, USP. OMEPRAZOLE Delayed-Release Capsules, USP, for oral use INITIAL U.S. APPROVAL: 19894
TRIETHYL CITRATEINACTIVE INGREDIENT8Z96QXD6UMThese highlights do not include all the information needed to use bupropion hydrochloride extended-release tablets (XL) safely and effectively. See full prescribing information for bupropion hydrochloride extended-release tablets (XL). Bupropion Hydrochloride Extended-Release Tablets, USP (XL) for oral use Initial U.S. Approval: 19853
TRIETHYL CITRATEINACTIVE INGREDIENT8Z96QXD6UMThese highlights do not include all the information needed to use oxybutynin chloride extended-release tablets safely and effectively. See full prescribing information for oxybutynin chloride extended-release tablets. Oxybutynin Chloride Extended-Release Tablets for oral use Initial U.S. Approval: 19751001
TRIETHYL CITRATEINACTIVE INGREDIENT8Z96QXD6UMThese highlights do not include all the information needed to use OMEPRAZOLE delayed-release capsules, USP safely and effectively. See full prescribing information for OMEPRAZOLE delayed-release capsules, USP . OMEPRAZOLE Delayed-Release Capsules, USP , for oral use INITIAL U.S. APPROVAL: 198915
TRIETHYL CITRATEINACTIVE INGREDIENT8Z96QXD6UMThese highlights do not include all the information needed to use simvastatin tablets safely and effectively. See full prescribing information for simvastatin tablets. Simvastatin Tablets USP for oral use Initial U.S. Approval: 19914
triethyl citrateINACTIVE INGREDIENT8Z96QXD6UMDiclofenac sodium and misoprostol delayed-release tablets3
TRIETHYL CITRATEINACTIVE INGREDIENT8Z96QXD6UMThese highlights do not include all the information needed to use simvastatin tablets safely and effectively. See full prescribing information for simvastatin tablets. Simvastatin Tablets USP for oral use Initial U.S. Approval: 199111
TRIETHYL CITRATEINACTIVE INGREDIENT8Z96QXD6UMThese highlights do not include all the information needed to use pantoprazole sodium delayed-release tablets safely and effectively. See full prescribing information for pantoprazole sodium delayed-release tablets. PANTOPRAZOLE sodium delayed-release tablets, USP, for oral use Initial U.S. Approval: 200014
TRIETHYL CITRATEINACTIVE INGREDIENT8Z96QXD6UMThese highlights do not include all the information needed to use Duloxetine Delayed-release Capsules safely and effectively. See full prescribing information for Duloxetine Delayed-release Capsules. DULOXETINE delayed-release capsules USP for oral use. Initial U.S. Approval: 20042
TRIETHYL CITRATEINACTIVE INGREDIENT8Z96QXD6UMBuPROPion Hydrochloride Tablets, USP3
TRIETHYL CITRATEINACTIVE INGREDIENT8Z96QXD6UMBuPROPion Hydrochloride Tablets, USP3
TRIETHYL CITRATEINACTIVE INGREDIENT8Z96QXD6UMThese highlights do not include all the information needed to use Pantoprazole Sodium Delayed-Release Tablets safely and effectively. See full prescribing information for Pantoprazole Sodium Delayed-Release Tablets. PANTOPRAZOLE SODIUM delayed-release tablets Initial U.S. approval: 20003
TRIETHYL CITRATEINACTIVE INGREDIENT8Z96QXD6UMClarithromycin for Oral Suspension, USP7
TRIETHYL CITRATEINACTIVE INGREDIENT8Z96QXD6UMVenlafaxine Hydrochloride Extended-Release Capsules Rx only3
TRIETHYL CITRATEINACTIVE INGREDIENT8Z96QXD6UMThese highlights do not include all the information needed to use Omeprazole safely and effectively. See full prescribing information for Omeprazole. Omeprazole (Omeprazole) CAPSULE for ORAL use. Initial U.S. Approval: 20133
TRIETHYL CITRATEINACTIVE INGREDIENT8Z96QXD6UMThese highlights do not include all the information needed to use PANTOPRAZOLE SODIUM safely and effectively. See full prescribing information for PANTOPRAZOLE SODIUM. PANTOPRAZOLE SODIUM (PANTOPRAZOLE SODIUM) TABLET for ORAL use. Initial U.S. Approval: 20073
TRIETHYL CITRATEINACTIVE INGREDIENT8Z96QXD6UMThese highlights do not include all the information needed to use AMOXICILLIN AND CLAVULANATE POTASSIUM, USP safely and effectively. See full prescribing information for AMOXICILLIN AND CLAVULANATE POTASSIUM, USP. Amoxicillin and Clavulanate Potassium Tablets, USP, for Oral Suspension, USP, and Chewable Tablets, USP Initial U.S. Approval: 1984 To reduce the development of drug-resistant bacteria and maintain the effectiveness of amoxicillin and clavulanate potassium and other antibacterial drugs, amoxicilli3
TRIETHYL CITRATEINACTIVE INGREDIENT8Z96QXD6UMThese highlights do not include all the information needed to use metoprolol succinate extended-release tablets safely and effectively. See full prescribing information for metoprolol succinate extended-release tablets. Metoprolol Succinate Extended-Release Tablets, USP for Oral Use INITIAL U.S. APPROVAL: 19925
TRIETHYL CITRATEINACTIVE INGREDIENT8Z96QXD6UMPRESCRIBING INFORMATION BuPROPion Hydrochloride Extended-Release Tablets (XL)3
TRIETHYL CITRATEINACTIVE INGREDIENT8Z96QXD6UMPOTASSIUM CHLORIDE EXTENDED-RELEASE CAPSULES, USP, 10 mEq3
TRIETHYL CITRATEINACTIVE INGREDIENT8Z96QXD6UMOmeprazole Delayed Release Tablets, 20 mg3
TRIETHYL CITRATEINACTIVE INGREDIENT8Z96QXD6UMRanitidine Tablets, USP2
TRIETHYL CITRATEINACTIVE INGREDIENT8Z96QXD6UMSimvastatin Tablets Tablet, Film Coated Rx Only. These highlights do not include all the information needed to use S imvastatin safely and effectively. See full prescribing information for S imvastatin. Simvastatin (Simvastatin) tablets for oral administration Initial U.S. Approval: 19912
TRIETHYL CITRATEINACTIVE INGREDIENT8Z96QXD6UMEcotrin Low Strength2
TRIETHYL CITRATEINACTIVE INGREDIENT8Z96QXD6UMb3180408-a3c0-4e02-8535-dea390a522777
TRIETHYL CITRATEINACTIVE INGREDIENT8Z96QXD6UMDrug facts3
TRIETHYL CITRATEINACTIVE INGREDIENT8Z96QXD6UMThese highlights do not include all the information needed to use omeprazole delayed-release capsules safely and effectively. See full prescribing information for omeprazole delayed-release capsules. Omeprazole Delayed-Release Capsules, USP Initial U.S. Approval: 19893
TRIETHYL CITRATEINACTIVE INGREDIENT8Z96QXD6UMfbf67fc8-8d29-4ae2-a533-75461754c5b14
TRIETHYL CITRATEINACTIVE INGREDIENT8Z96QXD6UMFULL PRESCRIBING INFORMATION These highlights do not include all the information needed to use OMEPRAZOLE DELAYED-RELEASE safely and effectively. See full prescribing information for OMEPRAZOLE DELAYED-RELEASE. OMEPRAZOLE DELAYED-RELEASE (omeprazole) capsule, delayed release for oral use Initial U.S. Approval: 19893
TRIETHYL CITRATEINACTIVE INGREDIENT8Z96QXD6UMThese highlights do not include all the information needed to use APRISO safely and effectively. See full prescribing information for APRISO. APRISO™ (mesalamine) extended-release capsules Initial U.S. Approval: 19872
TRIETHYL CITRATEINACTIVE INGREDIENT8Z96QXD6UMAmoxicillin Capsules, Tablets and Powder for Oral Suspension, USP6
triethyl citrateINACTIVE INGREDIENT8Z96QXD6UMThese highlights do not include all the information needed to use DEXILANT safely and effectively. See full prescribing information for DEXILANT. DEXILANT (dexlansoprazole) delayed-release capsules, for oral use Initial U.S. Approval: 1995 (lansoprazole)2
triethyl citrateINACTIVE INGREDIENT8Z96QXD6UMThese highlights do not include all the information needed to use CREON safely and effectively. See full prescribing information for CREON. CREON (pancrelipase) delayed-release capsules for oral use Initial U.S. Approval: 20095
triethyl citrateINACTIVE INGREDIENT8Z96QXD6UMARTHROTEC ® (diclofenac sodium/misoprostol) Tablets5
TRIETHYL CITRATEINACTIVE INGREDIENT8Z96QXD6UMThese highlights do not include all the information needed to use lansoprazole delayed-release capsules USP safely and effectively. See full prescribing information for lansoprazole delayed-release capsules USP. LANSOPRAZOLE delayed-release capsules USP for oral use Initial U.S. Approval: 19954
TRIETHYL CITRATEINACTIVE INGREDIENT8Z96QXD6UMThese highlights do not include all the information needed to use pantoprazole sodium delayed-release tablets USP safely and effectively. See full prescribing information for pantoprazole sodium delayed-release tablets USP. PANTOPRAZOLE sodium delayed-release tablets USP for oral use Initial U.S. Approval: 20002
TRIETHYL CITRATEINACTIVE INGREDIENT8Z96QXD6UMBisacodyl USP 5 mg Laxative3
TRIETHYL CITRATEINACTIVE INGREDIENT8Z96QXD6UMAppbutamone5
TRIETHYL CITRATEINACTIVE INGREDIENT8Z96QXD6UMAppbutamone-D12
TRIETHYL CITRATEINACTIVE INGREDIENT8Z96QXD6UM21b3b8a2-bfed-4945-954d-6a42ea61888f3
TRIETHYL CITRATEINACTIVE INGREDIENT8Z96QXD6UMThese highlights do not include all the information needed to use pantoprazole sodium delayed-release tablets, USP safely and effectively. See full prescribing information for pantoprazole sodium delayed-release tablets, USP. Pantoprazole Sodium Delayed-Release Tablets, USP Initial U.S. approval: 20002
TRIETHYL CITRATEINACTIVE INGREDIENT8Z96QXD6UMAspirin 81 mg Pain reliever3
triethyl citrateINACTIVE INGREDIENT8Z96QXD6UMDivalproex Sodium Delayed-Release Tablets, USP2
TRIETHYL CITRATEINACTIVE INGREDIENT8Z96QXD6UMThese highlights do not include all the information needed to use Didanosine Delayed-Release Capsules Enteric-Coated Pellets safely and effectively. See full prescribing information for Didanosine Delayed-Release Capsules Enteric-Coated Pellets. Initial U.S. Approval: 19912
TRIETHYL CITRATEINACTIVE INGREDIENT8Z96QXD6UMf6c30ba1-53d0-4f85-a515-81acfb922e735
TRIETHYL CITRATEINACTIVE INGREDIENT8Z96QXD6UMMetoprolol Succinate Extended-Release Tablets, USP 50 mg3
TRIETHYL CITRATEINACTIVE INGREDIENT8Z96QXD6UMMetoprolol Succinate Extended-Release Tablets, USP 25 mg3
TRIETHYL CITRATEINACTIVE INGREDIENT8Z96QXD6UMDIVALPROEX SODIUM DELAYED-RELEASE TABLETS4
TRIETHYL CITRATEINACTIVE INGREDIENT8Z96QXD6UMDIVALPROEX SODIUM DELAYED-RELEASE TABLETS USP 7439 7440 7441 Rx only4
TRIETHYL CITRATEINACTIVE INGREDIENT8Z96QXD6UM82f5292b-b113-4f10-9469-04386fa8e9d45
TRIETHYL CITRATEINACTIVE INGREDIENT8Z96QXD6UMDIVALPROEX SODIUM DR (DIVALPROEX SODIUM) TABLET, DELAYED RELEASE [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3983
TRIETHYL CITRATEINACTIVE INGREDIENT8Z96QXD6UMBUPROPION HYDROCHLORIDE TABLET, FILM COATED [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3955
TRIETHYL CITRATEINACTIVE INGREDIENT8Z96QXD6UMOMEPRAZOLE CAPSULE, DELAYED RELEASE [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]3741
triethyl citrateINACTIVE INGREDIENT8Z96QXD6UMWELLBUTRIN XL (BUPROPION HYDROCHLORIDE) TABLET, EXTENDED RELEASE [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3682
TRIETHYL CITRATEINACTIVE INGREDIENT8Z96QXD6UMAMOXICILLIN AND CLAVULANATE POTASSIUM TABLET, FILM COATED [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3628
triethyl citrateINACTIVE INGREDIENT8Z96QXD6UMARTHROTEC (DICLOFENAC SODIUM AND MISOPROSTOL) TABLET, FILM COATED [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3585
TRIETHYL CITRATEINACTIVE INGREDIENT8Z96QXD6UMNEXIUM (ESOMEPRAZOLE MAGNESIUM) CAPSULE, DELAYED RELEASE [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3473
TRIETHYL CITRATEINACTIVE INGREDIENT8Z96QXD6UMOMEPRAZOLE CAPSULE [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]3379
TRIETHYL CITRATEINACTIVE INGREDIENT8Z96QXD6UMVENLAFAXINE HYDROCHLORIDE TABLET, EXTENDED RELEASE [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3320
TRIETHYL CITRATEINACTIVE INGREDIENT8Z96QXD6UMBUPROPION HYDROCHLORIDE XL (BUPROPION HYDROCHLORIDE) TABLET, FILM COATED, EXTENDED RELEASE [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]3311
TRIETHYL CITRATEINACTIVE INGREDIENT8Z96QXD6UMPROTONIX DELAYED-RELEASE (PANTOPRAZOLE SODIUM) TABLET, DELAYED RELEASE [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3263
TRIETHYL CITRATEINACTIVE INGREDIENT8Z96QXD6UMNAPROXEN TABLET, DELAYED RELEASE [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]2091
TRIETHYL CITRATEINACTIVE INGREDIENT8Z96QXD6UMDEPAKOTE SPRINKLES (DIVALPROEX SODIUM) CAPSULE [ABBVIE INC.]1547
TRIETHYL CITRATEINACTIVE INGREDIENT8Z96QXD6UMTRILIPIX (FENOFIBRIC ACID) CAPSULE, DELAYED RELEASE [ABBVIE INC.]1459
TRIETHYL CITRATEINACTIVE INGREDIENT8Z96QXD6UMDIVALPROEX SODIUM TABLET, DELAYED RELEASE [BRYANT RANCH PREPACK]1005
TRIETHYL CITRATEINACTIVE INGREDIENT8Z96QXD6UMBUPROPION HYDROCHLORIDE TABLET, FILM COATED [BRYANT RANCH PREPACK]1002
TRIETHYL CITRATEINACTIVE INGREDIENT8Z96QXD6UMAMOXICILLIN/CLAVULANATE POTASSIUM TABLET [BRYANT RANCH PREPACK]1001
TRIETHYL CITRATEINACTIVE INGREDIENT8Z96QXD6UMDICLOFENAC SODIUM AND MISOPROSTOL TABLET, DELAYED RELEASE [BRYANT RANCH PREPACK]1001
TRIETHYL CITRATEINACTIVE INGREDIENT8Z96QXD6UMNEXIUM (ESOMEPRAZOLE MAGNESIUM) CAPSULE, DELAYED RELEASE [BRYANT RANCH PREPACK]1001
TRIETHYL CITRATEINACTIVE INGREDIENT8Z96QXD6UMPANTOPRAZOLE SODIUM TABLET, DELAYED RELEASE [BRYANT RANCH PREPACK]1001
TRIETHYL CITRATEINACTIVE INGREDIENT8Z96QXD6UMSIMVASTATIN TABLET, FILM COATED [BRYANT RANCH PREPACK]1001
TRIETHYL CITRATEINACTIVE INGREDIENT8Z96QXD6UMBUPROPION HYDROCHLORIDE TABLET, FILM COATED [BRYANT RANCH PREPACK]1000
TRIETHYL CITRATEINACTIVE INGREDIENT8Z96QXD6UMCIMETIDINE TABLET, FILM COATED [BRYANT RANCH PREPACK]1000
TRIETHYL CITRATEINACTIVE INGREDIENT8Z96QXD6UMCIMETIDINE TABLET, FILM COATED [BRYANT RANCH PREPACK]1000
TRIETHYL CITRATEINACTIVE INGREDIENT8Z96QXD6UMDULOXETINE CAPSULE, DELAYED RELEASE [BRYANT RANCH PREPACK]1000
TRIETHYL CITRATEINACTIVE INGREDIENT8Z96QXD6UMDULOXETINE CAPSULE, DELAYED RELEASE [BRYANT RANCH PREPACK]1000
TRIETHYL CITRATEINACTIVE INGREDIENT8Z96QXD6UMNEXIUM (ESOMEPRAZOLE MAGNESIUM) CAPSULE, DELAYED RELEASE [BRYANT RANCH PREPACK]1000
TRIETHYL CITRATEINACTIVE INGREDIENT8Z96QXD6UMPANTOPRAZOLE SODIUM TABLET, DELAYED RELEASE [BRYANT RANCH PREPACK]1000
TRIETHYL CITRATEINACTIVE INGREDIENT8Z96QXD6UMPAROXETINE HYDROCHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [BRYANT RANCH PREPACK]1000
TRIETHYL CITRATEINACTIVE INGREDIENT8Z96QXD6UMPAROXETINE HYDROCHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [BRYANT RANCH PREPACK]1000
TRIETHYL CITRATEINACTIVE INGREDIENT8Z96QXD6UMPAROXETINE HYDROCHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [BRYANT RANCH PREPACK]1000
TRIETHYL CITRATEINACTIVE INGREDIENT8Z96QXD6UMSIMVASTATIN TABLET, FILM COATED [BRYANT RANCH PREPACK]1000
TRIETHYL CITRATEINACTIVE INGREDIENT8Z96QXD6UMOMEPRAZOLE CAPSULE [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]430
TRIETHYL CITRATEINACTIVE INGREDIENT8Z96QXD6UMCYMBALTA (CYMBALTA) CAPSULE, DELAYED RELEASE [REMEDYREPACK INC. ]169
Triethyl citrateINACTIVE INGREDIENT8Z96QXD6UMRANITIDINE (RANITIDINE) TABLET [REMEDYREPACK INC. ]123
TRIETHYL CITRATEINACTIVE INGREDIENT8Z96QXD6UMDIVALPROEX SODIUM TABLET, DELAYED RELEASE [REMEDYREPACK INC. ]86
Triethyl citrateINACTIVE INGREDIENT8Z96QXD6UMCYMBALTA (DULOXETINE HYDROCHLORIDE) CAPSULE, DELAYED RELEASE [ELI LILLY AND COMPANY]66
triethyl citrateINACTIVE INGREDIENT8Z96QXD6UMCREON (PANCRELIPASE) CAPSULE, DELAYED RELEASE PELLETS CREON (PANCRELIPASE) CAPSULE, DELAYED RELEASE [ABBVIE INC.]57
Triethyl citrateINACTIVE INGREDIENT8Z96QXD6UMCYMBALTA (DULOXETINE HYDROCHLORIDE) CAPSULE, DELAYED RELEASE [PD-RX PHARMACEUTICALS, INC.]46
Triethyl citrateINACTIVE INGREDIENT8Z96QXD6UMCYMBALTA (DULOXETINE HYDROCHLORIDE) CAPSULE, DELAYED RELEASE [PD-RX PHARMACEUTICALS, INC.]45
TRIETHYL CITRATEINACTIVE INGREDIENT8Z96QXD6UMNEXIUM (ESOMEPRAZOLE MAGNESIUM) CAPSULE, DELAYED RELEASE NEXIUM (ESOMEPRAZOLE MAGNESIUM) GRANULE, DELAYED RELEASE [ASTRAZENECA LP]41
Triethyl citrateINACTIVE INGREDIENT8Z96QXD6UMPROZAC WEEKLY (FLUOXETINE HYDROCHLORIDE) CAPSULE, DELAYED RELEASE [ELI LILLY AND COMPANY]37
Triethyl citrateINACTIVE INGREDIENT8Z96QXD6UMTECFIDERA (DIMETHYL FUMARATE) KIT TECFIDERA (DIMETHYL FUMARATE) CAPSULE [BIOGEN INC.]32
TRIETHYL CITRATEINACTIVE INGREDIENT8Z96QXD6UMPRILOSEC (OMEPRAZOLE MAGNESIUM) CAPSULE, DELAYED RELEASE PRILOSEC (OMEPRAZOLE MAGNESIUM) GRANULE, DELAYED RELEASE [ASTRAZENECA LP]29
triethyl citrateINACTIVE INGREDIENT8Z96QXD6UMPREVACID (LANSOPRAZOLE) CAPSULE, DELAYED RELEASE PREVACID SOLUTAB (LANSOPRAZOLE) TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE [TAKEDA PHARMACEUTICALS AMERICA, INC.]28
TRIETHYL CITRATEINACTIVE INGREDIENT8Z96QXD6UMCARBATROL (CARBAMAZEPINE) CAPSULE, EXTENDED RELEASE [SHIRE US MANUFACTURING INC.]26
TRIETHYL CITRATEINACTIVE INGREDIENT8Z96QXD6UMLIALDA (MESALAMINE) TABLET, DELAYED RELEASE [SHIRE US MANUFACTURING INC.]26
TRIETHYL CITRATEINACTIVE INGREDIENT8Z96QXD6UMPROTONIX DELAYED-RELEASE (PANTOPRAZOLE SODIUM) TABLET, DELAYED RELEASE PROTONIX DELAYED-RELEASE (PANTOPRAZOLE SODIUM) GRANULE, DELAYED RELEASE [WYETH PHARMACEUTICALS INC., A SUBSIDIARY OF PFIZER INC.]26
TRIETHYL CITRATEINACTIVE INGREDIENT8Z96QXD6UMDIVALPROEX SODIUM CAPSULE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]25
TRIETHYL CITRATEINACTIVE INGREDIENT8Z96QXD6UMLAMICTAL XR (LAMOTRIGINE) TABLET, FILM COATED, EXTENDED RELEASE LAMICTAL XR (LAMOTRIGINE) KIT [GLAXOSMITHKLINE LLC]25
TRIETHYL CITRATEINACTIVE INGREDIENT8Z96QXD6UMPANTOPRAZOLE SODIUM TABLET, DELAYED RELEASE [KREMERS URBAN PHARMACEUTICALS INC.]25
TRIETHYL CITRATEINACTIVE INGREDIENT8Z96QXD6UMBUPROPION HYDROCHLORIDE XL (BUPROPION HYDROCHLORIDE) TABLET, FILM COATED, EXTENDED RELEASE [ACTAVIS PHARMA, INC.]23
TRIETHYL CITRATEINACTIVE INGREDIENT8Z96QXD6UMDIVALPROEX SODIUM DELAYED RELEASE (SPRINKLE) (DIVALPROEX SODIUM) CAPSULE [SANDOZ INC.]23
TRIETHYL CITRATEINACTIVE INGREDIENT8Z96QXD6UMDOXYCYCLINE HYCLATE TABLET, DELAYED RELEASE [ACTAVIS PHARMA, INC.]23
TRIETHYL CITRATEINACTIVE INGREDIENT8Z96QXD6UMOMEPRAZOLE CAPSULE, DELAYED RELEASE [KREMERS URBAN PHARMACEUTICALS INC.]23
TRIETHYL CITRATEINACTIVE INGREDIENT8Z96QXD6UMDICLOFENAC SODIUM AND MISOPROSTOL TABLET, DELAYED RELEASE [ACTAVIS PHARMA, INC.]22
TRIETHYL CITRATEINACTIVE INGREDIENT8Z96QXD6UMARTHROTEC (DICLOFENAC SODIUM AND MISOPROSTOL) TABLET, FILM COATED [G.D. SEARLE LLC DIVISION OF PFIZER INC]21
TRIETHYL CITRATEINACTIVE INGREDIENT8Z96QXD6UMDEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE, AMPHETAMINE SULFATE CAPSULE, EXTENDED RELEASE [ACTAVIS PHARMA, INC.]21
TRIETHYL CITRATEINACTIVE INGREDIENT8Z96QXD6UMDIVALPROEX SODIUM DELAYED-RELEASE (DIVALPROEX SODIUM) TABLET, FILM COATED [QUALITEST PHARMACEUTICALS]21
TRIETHYL CITRATEINACTIVE INGREDIENT8Z96QXD6UMFOCALIN XR (DEXMETHYLPHENIDATE HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [NOVARTIS PHARMACEUTICALS CORPORATION]21
TRIETHYL CITRATEINACTIVE INGREDIENT8Z96QXD6UMADDERALL XR (DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE SULFATE AND AMPHETAMINE ASPARTATE) CAPSULE, EXTENDED RELEASE [SHIRE US MANUFACTURING INC.]20
TRIETHYL CITRATEINACTIVE INGREDIENT8Z96QXD6UMMETOPROLOL SUCCINATE TABLET, FILM COATED, EXTENDED RELEASE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]20
TRIETHYL CITRATEINACTIVE INGREDIENT8Z96QXD6UMRITALIN LA (METHYLPHENIDATE HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [NOVARTIS PHARMACEUTICALS CORPORATION]20
TRIETHYL CITRATEINACTIVE INGREDIENT8Z96QXD6UMOMEPRAZOLE (OMEPRAZOLE) CAPSULE, DELAYED RELEASE [AVPAK]19